Annual EBITDA
-$78.88 M
-$2.15 M-2.80%
31 December 2023
Summary:
PMV Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization is currently -$78.88 million, with the most recent change of -$2.15 million (-2.80%) on 31 December 2023. During the last 3 years, it has fallen by -$44.25 million (-127.80%). PMVP annual EBITDA is now -325.11% below its all-time high of -$18.55 million, reached on 31 December 2018.PMVP EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$21.52 M
-$1.72 M-8.68%
30 September 2024
Summary:
PMV Pharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization is currently -$21.52 million, with the most recent change of -$1.72 million (-8.68%) on 30 September 2024. Over the past year, it has dropped by -$2.25 million (-11.66%). PMVP quarterly EBITDA is now -239.76% below its all-time high of -$6.33 million, reached on 30 September 2019.PMVP Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$77.72 M
-$2.25 M-2.98%
30 September 2024
Summary:
PMV Pharmaceuticals TTM earnings before interest, taxes, depreciation & amortization is currently -$77.72 million, with the most recent change of -$2.25 million (-2.98%) on 30 September 2024. Over the past year, it has increased by +$3.70 million (+4.55%). PMVP TTM EBITDA is now -1127.18% below its all-time high of -$6.33 million, reached on 30 September 2019.PMVP TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PMVP EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -2.8% | -11.7% | +4.5% |
| 3 y3 years | -127.8% | -43.3% | -55.3% |
| 5 y5 years | -325.1% | -239.8% | -1127.2% |
PMVP EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -127.8% | at low | -43.3% | at low | -55.3% | +4.6% |
| 5 y | 5 years | -325.1% | at low | -239.8% | at low | -1127.2% | +4.6% |
| alltime | all time | -325.1% | at low | -239.8% | at low | -1127.2% | +4.6% |
PMV Pharmaceuticals EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$21.52 M(+8.7%) | -$77.72 M(+3.0%) |
| June 2024 | - | -$19.80 M(+10.9%) | -$75.47 M(+0.1%) |
| Mar 2024 | - | -$17.86 M(-3.7%) | -$75.42 M(-4.4%) |
| Dec 2023 | -$78.88 M(+2.8%) | -$18.54 M(-3.8%) | -$78.88 M(-3.1%) |
| Sept 2023 | - | -$19.27 M(-2.4%) | -$81.42 M(-0.0%) |
| June 2023 | - | -$19.75 M(-7.3%) | -$81.45 M(+2.5%) |
| Mar 2023 | - | -$21.31 M(+1.1%) | -$79.50 M(+3.6%) |
| Dec 2022 | -$76.72 M(+32.3%) | -$21.09 M(+9.3%) | -$76.73 M(+3.6%) |
| Sept 2022 | - | -$19.30 M(+8.4%) | -$74.03 M(+6.1%) |
| June 2022 | - | -$17.80 M(-3.9%) | -$69.75 M(+7.4%) |
| Mar 2022 | - | -$18.54 M(+0.8%) | -$64.93 M(+12.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$57.99 M(+67.5%) | -$18.39 M(+22.5%) | -$57.99 M(+15.9%) |
| Sept 2021 | - | -$15.02 M(+15.7%) | -$50.03 M(+14.6%) |
| June 2021 | - | -$12.98 M(+11.9%) | -$43.64 M(+12.9%) |
| Mar 2021 | - | -$11.60 M(+11.1%) | -$38.66 M(+11.7%) |
| Dec 2020 | -$34.62 M(+31.9%) | -$10.44 M(+21.0%) | -$34.62 M(+10.1%) |
| Sept 2020 | - | -$8.63 M(+7.9%) | -$31.44 M(+7.9%) |
| June 2020 | - | -$8.00 M(+5.8%) | -$29.15 M(+37.8%) |
| Mar 2020 | - | -$7.56 M(+4.1%) | -$21.15 M(+55.6%) |
| Dec 2019 | -$26.25 M(+41.5%) | -$7.26 M(+14.6%) | -$13.59 M(+114.6%) |
| Sept 2019 | - | -$6.33 M | -$6.33 M |
| Dec 2018 | -$18.55 M | - | - |
FAQ
- What is PMV Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for PMV Pharmaceuticals?
- What is PMV Pharmaceuticals annual EBITDA year-on-year change?
- What is PMV Pharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for PMV Pharmaceuticals?
- What is PMV Pharmaceuticals quarterly EBITDA year-on-year change?
- What is PMV Pharmaceuticals TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for PMV Pharmaceuticals?
- What is PMV Pharmaceuticals TTM EBITDA year-on-year change?
What is PMV Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of PMVP is -$78.88 M
What is the all time high annual EBITDA for PMV Pharmaceuticals?
PMV Pharmaceuticals all-time high annual earnings before interest, taxes, depreciation & amortization is -$18.55 M
What is PMV Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, PMVP annual earnings before interest, taxes, depreciation & amortization has changed by -$2.15 M (-2.80%)
What is PMV Pharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of PMVP is -$21.52 M
What is the all time high quarterly EBITDA for PMV Pharmaceuticals?
PMV Pharmaceuticals all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$6.33 M
What is PMV Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, PMVP quarterly earnings before interest, taxes, depreciation & amortization has changed by -$2.25 M (-11.66%)
What is PMV Pharmaceuticals TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of PMVP is -$77.72 M
What is the all time high TTM EBITDA for PMV Pharmaceuticals?
PMV Pharmaceuticals all-time high TTM earnings before interest, taxes, depreciation & amortization is -$6.33 M
What is PMV Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, PMVP TTM earnings before interest, taxes, depreciation & amortization has changed by +$3.70 M (+4.55%)